Summit Therapeutics Inc. · NASDAQ:SMMT

Summit Therapeutics Inc. shareholders

As of Sep 30, 2026, 291 institutions reported holding Summit Therapeutics Inc., 16.8% of its shares. Largest: Baker Bros. Advisors LP, Vanguard and BlackRock. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Summit Therapeutics Inc.ChangeFiled
Baker Bros. Advisors LP32.8M4.1%no changeNov 16, 2026
Vanguard15.2M1.9%+3.37MNov 13, 2026
BlackRock10.4M1.3%+835KNov 13, 2026
Fidelity8.14M1.0%−1.91MNov 10, 2026
State Street6.09M0.76%−3.44MNov 12, 2026
T. Rowe Price5.3M0.66%+1.4MNov 16, 2026
Citadel3.78M0.47%+2.06MNov 16, 2026
Geode Capital3.49M0.44%+61,961Nov 6, 2026
UBS3.22M0.40%−2.1MNov 16, 2026
Kynam Capital Management, LP3M0.38%+1.8MNov 16, 2026

Summit Therapeutics Inc. insider trades